Company Overview

PhotonMD is a medical device company focused on identifying and developing natural, chemical free, non-UV containing light technologies that will enable the treatment of chronic diseases. Our products will treat various health conditions using Modulated Light Therapy (MLT ) technology. MLT is a proprietary unique application of specific wavelengths of light that play an important role in unlocking key elements in human physiology. One of the keys to modulating the immune system is the power to control nitric oxide (NO) and reactive oxygen species. PhotonMD uses innovative, precision photomedicine devices to create safe, therapeutic solutions for aesthetic, autoimmune, inflammatory diseases and other conditions susceptible to light-based healing.

"There are significant opportunities to examine the
biological responses to light and nitric oxide
focusing first on dermatological applications."
-Nick Medendorp Jr., Ph.D

Board Of Directors
Mr. Hunter was the founding investor of Novan, Inc. and served as the Company’s Chairman for eight years, personally orchestrating the fund raising of over $100M in private financing. His 25 year track record of successfully raising capital for technology companies in both the public and private sectors began as a Co-founder of Cree, Inc. (NASDAQ:CREE). Neal served multiple roles at Cree, including as the public company CEO and Chairman from 1994 to 2001 and then Chairman until 2005. He was also instrumental in the creation and start-up of LED Lighting Fixtures, Inc. which he co-founded in 2005 to accelerate the use of LEDs in general illumination applications and was subsequently sold in 2008 for over $100M. In total, Neal has been either co-founder, founder, co-founding investor or founding investor in over ten significant start-up ventures in the areas of semiconductor materials & devices, aesthetic materials, software, gourmet food service, commercial and residential real estate, LED lighting systems and life sciences. His proven expertise in technology transfer, from inception of innovations to the creation of market-changing products, has led to the transition to his new role as Chairman of KnowBio, LLC, an RTP based incubator for platform based medical technology and biotechnology companies.
Dr. Stasko is co-founder, President and Chief Science Officer of Novan, Inc. He is the inventor of the core Novan technology and of more than 100 patent filings, 19 of which have issued, and has authored several peer-reviewed manuscripts pertaining to the chemical storage and controlled release of nitric oxide. Dr. Stasko led Novan through each of its private financings totaling more than $100 million, as well as the award of government grants and contracts totaling $15 million, the latter ultimately resulting in Novan’s national recognition as a Tibbetts Award winner for excellence in Small Business Innovation Research.
Dr. Medendorp is co-founder, President and Chief Executive Officer. Nick is a seasoned technology and product development leader with over 80 U.S. patents in electronic materials, LED and lighting products. He has over 20 years of experience in the technology development industry and has served in a broad range of functions throughout his career, including research and product development, operations management and marketing. Nick previously served as Vice President of Medical Devices for Novan, Inc., the industry leader in nitric oxide (NO) pharmaceutical drug development, where he was responsible for the development of innovative medical devices for a variety of hard to treat conditions. Prior to his work at Novan, Nick served as Vice President of Research & Development for Cree, Inc., where he was responsible for product development, engineering, compliance and advanced technology development for the LED Lighting Division. He joined Cree in 2004 during the creation of the LED Components division, where he held positions as the Director of Operations, Director of Research and Development and Director of Marketing. In his former work, Nick held a variety of engineering and management positions at Agility Communications, Inc. (acquired by JDSU, Inc.) and Motorola, Inc. Nick received his B.S., M.S., and Ph.D. in Materials Engineering from Purdue University.
Team
Dr. Medendorp is co-founder, President and Chief Executive Officer. Nick is a seasoned technology and product development leader with over 80 U.S. patents in electronic materials, LED and lighting products. He has over 20 years of experience in the technology development industry and has served in a broad range of functions throughout his career, including research and product development, operations management and marketing. Nick previously served as Vice President of Medical Devices for Novan, Inc., the industry leader in nitric oxide (NO) pharmaceutical drug development, where he was responsible for the development of innovative medical devices for a variety of hard to treat conditions. Prior to his work at Novan, Nick served as Vice President of Research & Development for Cree, Inc., where he was responsible for product development, engineering, compliance and advanced technology development for the LED Lighting Division. He joined Cree in 2004 during the creation of the LED Components division, where he held positions as the Director of Operations, Director of Research and Development and Director of Marketing. In his former work, Nick held a variety of engineering and management positions at Agility Communications, Inc. (acquired by JDSU, Inc.) and Motorola, Inc. Nick received his B.S., M.S., and Ph.D. in Materials Engineering from Purdue University.
As a Business Analyst for PhotonMD, Mr. Forbes is responsible for the exploration and evaluation of diseases and therapeutic areas capable of being treated with the therapeutic properties of Modulated Light Therapy. In addition to conducting early indication research and market evaluations, he also conducts market research to help PhotonMD better understand the pain points and unmet needs of patients which can be treated with Modulated Light Therapy. Prior to joining PhotonMD, Joseph worked as an analyst for Promidian Consulting, a management consulting firm serving clients in the pharmaceutical, biotechnology, and life sciences industries. He received his BSBA in Finance from Creighton University.
Mr. Lay, is Director of Design and Development. He is responsible for new concept development, brand design and understanding the patient journey. He has over 20 years’ experience in product design, engineering and managing product development. Michael formerly served as Associate Director of Mechanical Engineering, Medical Devices for Novan, Inc. and prior to that as Advanced Concept Development Manager for the Lighting division of Cree. He is an inventor on over 85 issued US patents and recipient of the International Design Excellence Awards (IDEA) Silver & Bronze awards. His portfolio includes a diverse set of products from fire safety, lighting, exhibits, soft goods and medical products. He received his B.S. of Industrial Design from Auburn University.
Mr. Womble is the Manager of Mechanical Engineering at PhotonMD, Inc. with over 13 years of experience in product development and new product introduction of medical devices. He is responsible for mechanical design and development, electro-mechanical system integration, verification and validation, and manufacturing of new products. Matt has formerly served at Robling Medical, Inc. as Project Engineering Manager providing hands-on leadership of early stage manufacturing builds for design verification and validation, manufacturing validations, and initial production. Prior to that, Matt served in multiple engineering roles for Baxano Surgical, Inc. (formerly TranS1, Inc.) where he designed, developed, and launched implants and associated instrumentation for minimally invasive lumbar spine fusion. Matt received dual BSc degrees from North Carolina State University in Biological Engineering and Biomedical Engineering. He also received a MSc Degree from Virginia Commonwealth University in Biomedical Engineering.
Mr. Zarnosky is the Director of Accounting and Administration. Prior to joining PhotonMD, he was the Director of Accounting and Finance for a SaaS based Healthcare Technology company, Medfusion, Inc. Previously he held various finance and accounting positions with Cree, Inc. and was a Manager at PricewaterhouseCoopers, specializing in publicly traded and private companies with a focus in the consumer products sector. Mr. Zarnosky started his career as Assistant State Auditor in Ohio and then in North Carolina. He received his BSBA in Accounting from Youngstown State University, his MS in Accounting from Kent State University, and his MBA from East Carolina University.
Scientific Advisory Board
Dr. David McDaniel is Board Certified by the American Board of Dermatology. He is a Co-Director of the Hampton University Skin of Color Research Institute, Adjunct Professor in the School of Science, Hampton University, as well as an Adjunct Assistant Professor, Department of Biological Sciences for Old Dominion University. In addition to his dermatology training, he has special training in physical chemistry, light physics, pathology and dermatopathology, botany and emergency medicine.
Dr. Deanne Mraz Robinson is a board certified dermatologist, Director of the Body Sculpting Center at Connecticut Dermatology Group, and a national and international lecturer on Cosmetic and Laser Dermatology. Dr. Robinson obtained her Medical Degree from University of Rochester School of Medicine and Dentistry, then went on to complete her dermatology residency at Yale New Haven Hospital in New Haven, CT where she became Chief-Resident. She then completed a fellowship in Cosmetic, Laser, and Surgical Dermatology at Skincare Physicians in Chestnut Hill, MA..
A Professor of Chemistry at the University of North Carolina at Chapel Hill where he has developed a dynamic research program in the field of nitric oxide. With nearly 20 years of experience as a chemist, he has published >100 peer-reviewed articles on nitric oxide-related technologies. He has a long-standing interest in developing macromolecular scaffolds that store and release nitric oxide for drug delivery and disease management applications. Dr. Schoenfisch is a Novan Co-Founder and previous Board member.